Home › Funds › THIRD AVENUE MANAGEMENT LLC › COLL

THIRD AVENUE MANAGEMENT LLC position in COLL

COLLEGIUM PHARMACEUTICAL INC · Health Care

THIRD AVENUE MANAGEMENT LLC reported holding 222,738 shares of COLL (COLLEGIUM PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$4.9M, representing 0.82% of its reported portfolio and ranking #37 among its reported holdings. THIRD AVENUE MANAGEMENT LLC has disclosed COLL holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)222.74K sh
Reported value held$4.86M
Portfolio Weight0.82%
First reportedQ4 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How THIRD AVENUE MANAGEMENT LLC's COLL position evolved

THIRD AVENUE MANAGEMENT LLC first disclosed a stake in COLL in Q4 2023 at 83,120 shares (US$2.6M). The position peaked in Q4 2025 at 203,401 shares, worth US$9.4M. Across 12 filings, THIRD AVENUE MANAGEMENT LLC increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 222,738 shares valued at US$4.9M — an increase of 40,093 shares quarter over quarter.. Notable position changes include a 30% increase in Q1 2024 (shares fell 17% over the following quarter), a 69% increase in Q2 2024 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 83.12K $2.56M New
Q1 2024 108.12K $4.20M Add
Q2 2024 182.28K $5.87M Add
Q3 2024 182.65K $7.06M Hold
Q4 2024 203.40K $5.83M Add
Q1 2025 203.40K $6.07M Hold
Q2 2025 203.40K $6.01M Hold
Q3 2025 203.40K $7.15M Hold
Q4 2025 203.40K $9.42M Hold
Q1 2026 155.14K $5.13M Reduce
Q2 2026 182.65K $6.61M Add
Q3 2026 222.74K $4.86M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COLL and 13F data

COLL (COLLEGIUM PHARMACEUTICAL INC) is a Health Care company. 29 other funds we track also report a position in COLL — the largest reported positions include TENOR CAPITAL MANAGEMENT Co., L.P. (US$85.8M), EVENTIDE ASSET MANAGEMENT, LLC (US$49.3M), GOLDENTREE ASSET MANAGEMENT LP (US$26.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COLL

All COLL fund holders →

FAQ

How long has THIRD AVENUE MANAGEMENT LLC held COLL?

THIRD AVENUE MANAGEMENT LLC has disclosed COLL holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is THIRD AVENUE MANAGEMENT LLC's current position in COLL?

As of Q3 2026, THIRD AVENUE MANAGEMENT LLC holds 222.74K shares of COLL (COLLEGIUM PHARMACEUTICAL INC), valued at $4.86M, representing 0.82% of its reported portfolio and ranking #37.

Has THIRD AVENUE MANAGEMENT LLC been buying or selling COLL?

In the latest 13F filing (Q3 2026), THIRD AVENUE MANAGEMENT LLC increased its position in COLL. The position peaked in Q4 2025 at 203.40K shares.

Which other funds hold COLL?

Other major institutional holders of COLL include TENOR CAPITAL MANAGEMENT Co., L.P., EVENTIDE ASSET MANAGEMENT, LLC, GOLDENTREE ASSET MANAGEMENT LP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.